应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ASND Ascendis Pharma A/S
交易中 05-03 13:29:06 EDT
138.49
-2.61
-1.85%
最高
142.36
最低
135.16
成交量
30.33万
今开
141.96
昨收
141.10
日振幅
5.10%
总市值
79.12亿
流通市值
78.49亿
总股本
5,713万
成交额
4,199万
换手率
0.54%
流通股本
5,667万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
坎托菲茨杰拉德公司:重申Ascendis Pharma(ASND.US)评级,由增持调整至增持评级, 目标价173.00美元。
智通财经 · 05-03 23:05
坎托菲茨杰拉德公司:重申Ascendis Pharma(ASND.US)评级,由增持调整至增持评级, 目标价173.00美元。
维升药业三冲港交所IPO:增高针数据不及竞品前景待考
华尔街见闻 · 03-25
维升药业三冲港交所IPO:增高针数据不及竞品前景待考
Ascendis Pharma A/S盘中异动 临近收盘急速跳水5.01%
自选股智能写手 · 02-29
Ascendis Pharma A/S盘中异动 临近收盘急速跳水5.01%
Ascendis Pharma A/S盘中异动 早盘股价大涨5.01%
自选股智能写手 · 02-17
Ascendis Pharma A/S盘中异动 早盘股价大涨5.01%
Ascendis Pharma A/S2023财年实现净利润-5.20亿美元,同比增加15.17%
自选股智能写手 · 02-11
Ascendis Pharma A/S2023财年实现净利润-5.20亿美元,同比增加15.17%
美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司
Reuters · 02-08
美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司
Ascendis Pharma A/S盘中异动 股价大涨5.04%
自选股智能写手 · 02-02
Ascendis Pharma A/S盘中异动 股价大涨5.04%
Ascendis Pharma A/S盘中异动 大幅上涨5.08%
自选股智能写手 · 01-09
Ascendis Pharma A/S盘中异动 大幅上涨5.08%
Ascendis Pharma A/S盘中异动 大幅拉升5.12%
自选股智能写手 · 2023-12-14
Ascendis Pharma A/S盘中异动 大幅拉升5.12%
Ascendis Pharma A/S盘中异动 早盘急速下跌5.03%报102.27美元
自选股智能写手 · 2023-12-11
Ascendis Pharma A/S盘中异动 早盘急速下跌5.03%报102.27美元
Ascendis Pharma A/S跌0.45% 股价跌破100美元大关
自选股智能写手 · 2023-12-01
Ascendis Pharma A/S跌0.45% 股价跌破100美元大关
Ascendis Pharma A/S涨3.67% 股价突破100美元大关
自选股智能写手 · 2023-11-30
Ascendis Pharma A/S涨3.67% 股价突破100美元大关
Ascendis Pharma A/S盘中异动 股价大涨5.13%报95.27美元
自选股智能写手 · 2023-11-30
Ascendis Pharma A/S盘中异动 股价大涨5.13%报95.27美元
Ascendis Pharma A/S盘中异动 股价大涨5.10%报93.99美元
自选股智能写手 · 2023-11-14
Ascendis Pharma A/S盘中异动 股价大涨5.10%报93.99美元
Ascendis Pharma A/S2023财年第三财季实现净利润-1.76亿美元,同比减少3.53%
自选股智能写手 · 2023-11-13
Ascendis Pharma A/S2023财年第三财季实现净利润-1.76亿美元,同比减少3.53%
加载更多
公司概况
公司名称:
Ascendis Pharma A/S
所属市场:
NASDAQ
上市日期:
--
主营业务:
Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司,该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品,TransCon人生长激素或生长激素TransCon,每周一次给药治疗生长激素缺乏症以及其他疾病。
发行价格:
--
{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":138.49,"timestamp":1714757293980,"preClose":141.1,"halted":0,"volume":303277,"delay":0,"floatShares":56674679,"shares":57131365,"eps":-9.454429,"marketStatus":"交易中","marketStatusCode":2,"change":-2.61,"latestTime":"05-03 13:29:06 EDT","open":141.96,"high":142.36,"low":135.1588,"amount":41993492.4266,"amplitude":0.051036,"askPrice":139.04,"askSize":80,"bidPrice":138.19,"bidSize":205,"shortable":3,"etf":0,"ttmEps":-9.454429,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714766400000},"adr":1,"listingDate":1422421200000,"adjPreClose":141.1,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":141.5,"preClose":141.1,"latestTime":"18:24 EDT","volume":14846,"amount":2101992.7,"timestamp":1714688649136},"volumeRatio":1.658923},"requestUrl":"/m/hq/s/ASND","defaultTab":"news","newsList":[{"id":"2432904334","title":"坎托菲茨杰拉德公司:重申Ascendis Pharma(ASND.US)评级,由增持调整至增持评级, 目标价173.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432904334","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432904334?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:05","pubTimestamp":1714748732,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:重申Ascendis Pharma(ASND.US)评级,由增持调整至增持评级, 目标价173.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422535118","title":"维升药业三冲港交所IPO:增高针数据不及竞品前景待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2422535118","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2422535118?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:50","pubTimestamp":1711331414,"startTime":"0","endTime":"0","summary":"失之毫厘,差之千里?","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/content_default_5.jpg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/content_default_5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3711208","is_publish_highlight":false,"gpt_icon":0},{"id":"2415398588","title":"Ascendis Pharma A/S盘中异动 临近收盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415398588","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415398588?lang=zh_cn&edition=full","pubTime":"2024-02-29 04:31","pubTimestamp":1709152307,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日04时31分,Ascendis Pharma A/S股票出现波动,股价急速下挫5.01%。截至发稿,该股报147.55美元/股,成交量34.9456万股,换手率0.62%,振幅4.50%。Ascendis Pharma A/S股票所在的生物技术行业中,整体跌幅为0.51%。其相关个股中,Vivani Medical Inc、Vtv Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大,Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃,换手率分别为6580.68%、280.20%、183.10%,振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc,振幅分别为424.75%、219.84%、129.29%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229043147861d9b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229043147861d9b3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412667723","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412667723","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412667723?lang=zh_cn&edition=full","pubTime":"2024-02-17 00:21","pubTimestamp":1708100474,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日00时21分,Ascendis Pharma A/S股票出现波动,股价大幅上涨5.01%。截至发稿,该股报154.57美元/股,成交量14.2446万股,换手率0.25%,振幅6.03%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.25%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170021147911c85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170021147911c85f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410078395","title":"Ascendis Pharma A/S2023财年实现净利润-5.20亿美元,同比增加15.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410078395","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410078395?lang=zh_cn&edition=full","pubTime":"2024-02-11 00:23","pubTimestamp":1707582227,"startTime":"0","endTime":"0","summary":"12月31日,Ascendis Pharma A/S公布财报,公告显示公司2023财年净利润为-5.20亿美元,同比增加15.17%;其中营业收入为2.88亿美元,同比增加435.52%,每股基本收益为-9.25美元。从资产负债表来看,Ascendis Pharma A/S总负债10.73亿美元,其中短期债务28.06百万美元,资产负债比为0.85,流动比率为3.56。机构评级:截至2023年12月31日,当前有13家机构对Ascendis Pharma A/S目标价做出预测,其中目标均价为171.27美元,其中最低目标价为116.61美元,最高目标价为225.21美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402110023568180a4ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402110023568180a4ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409761527","title":"美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2409761527","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409761527?lang=zh_cn&edition=full","pubTime":"2024-02-08 16:00","pubTimestamp":1707379255,"startTime":"0","endTime":"0","summary":" 路透2月8日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括Idexx Laboratories、Fleetcor Technologies和Huntington Ingalls Industries 。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408509766","title":"Ascendis Pharma A/S盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408509766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408509766?lang=zh_cn&edition=full","pubTime":"2024-02-02 02:28","pubTimestamp":1706812098,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日02时28分,Ascendis Pharma A/S股票出现异动,股价大幅拉升5.04%。截至发稿,该股报136.48美元/股,成交量14.6935万股,换手率0.26%,振幅5.51%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.87%。其相关个股中,Protagenic Therapeutics Inc C/Wts 29/04/2026 、Neurobo Pharmaceuticals Inc、Gri Bio Inc涨幅较大,Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃,换手率分别为2664.31%、1185.14%、1025.74%,振幅较大的相关个股有Gri Bio Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc,振幅分别为207.75%、69.32%、64.22%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202022818790e446e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202022818790e446e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402988089","title":"Ascendis Pharma A/S盘中异动 大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402988089","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402988089?lang=zh_cn&edition=full","pubTime":"2024-01-09 01:57","pubTimestamp":1704736637,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日01时57分,Ascendis Pharma A/S股票出现波动,股价快速上涨5.08%。截至发稿,该股报136.32美元/股,成交量15.874万股,换手率0.28%,振幅6.43%。Ascendis Pharma A/S股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Harpoon Therapeutics Inc、Ambrx Biopharma Inc 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Neximmune Inc、Cyclacel Pharmaceuticals Inc、Cellectar Biosciences Inc较为活跃,换手率分别为474.38%、382.87%、225.83%,振幅较大的相关个股有Elevation Oncology Inc、Nkarta Inc、Biocardia Inc C/Wts 06/08/2024,振幅分别为76.38%、72.61%、63.33%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401090157177a395692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401090157177a395692&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391675594","title":"Ascendis Pharma A/S盘中异动 大幅拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391675594","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391675594?lang=zh_cn&edition=full","pubTime":"2023-12-14 04:18","pubTimestamp":1702498713,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日04时18分,Ascendis Pharma A/S股票出现异动,股价大幅上涨5.12%。截至发稿,该股报115.84美元/股,成交量86.556万股,换手率1.53%,振幅5.14%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为3.31%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231214041833806b3105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231214041833806b3105&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2390357055","title":"Ascendis Pharma A/S盘中异动 早盘急速下跌5.03%报102.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2390357055","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2390357055?lang=zh_cn&edition=full","pubTime":"2023-12-11 22:53","pubTimestamp":1702306394,"startTime":"0","endTime":"0","summary":"北京时间2023年12月11日22时53分,Ascendis Pharma A/S股票出现异动,股价快速跳水5.03%。截至发稿,该股报102.27美元/股,成交量10.9169万股,换手率0.19%,振幅5.28%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Pasithea Therapeutics Corp、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Pasithea Therapeutics Corp、Altamira Therapeutics Ltd、Tharimmune Inc较为活跃,换手率分别为224.30%、110.91%、89.36%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为130.12%、78.64%、20.70%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231211225314806b2aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231211225314806b2aa7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2388256130","title":"Ascendis Pharma A/S跌0.45% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2388256130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388256130?lang=zh_cn&edition=full","pubTime":"2023-12-01 23:33","pubTimestamp":1701444821,"startTime":"0","endTime":"0","summary":"北京时间2023年12月01日23时33分,Ascendis Pharma A/S股票出现异动,股价急速下跌0.45%。截至发稿,该股报99.98美元/股,成交量3.9898万股,换手率0.07%,振幅2.10%。Ascendis Pharma A/S股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Clene Inc C/Wts 30/12/2025 、Altimmune Inc涨幅较大,Clearmind Medicine Inc、Altimmune Inc、Aditxt Inc较为活跃,换手率分别为1018.27%、95.21%、68.42%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Altimmune Inc,振幅分别为57.14%、56.80%、54.75%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231201233341806b0e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231201233341806b0e48&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387428211","title":"Ascendis Pharma A/S涨3.67% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2387428211","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387428211?lang=zh_cn&edition=full","pubTime":"2023-11-30 22:47","pubTimestamp":1701355643,"startTime":"0","endTime":"0","summary":"北京时间2023年11月30日22时47分,Ascendis Pharma A/S股票出现波动,股价急速拉升3.67%。截至发稿,该股报100.64美元/股,成交量1.0344万股,换手率0.02%,振幅2.85%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Revelation Biosciences Inc C/Wts 10/01/2027 、Immunogen Inc、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大,Aditxt Inc、Clearmind Medicine Inc、安皮奥制药较为活跃,换手率分别为770.37%、579.13%、434.05%,振幅较大的相关个股有安皮奥制药、Altamira Therapeutics Ltd、Zyversa Therapeutics Inc,振幅分别为42.86%、38.63%、33.09%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302247258309d55e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302247258309d55e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387453012","title":"Ascendis Pharma A/S盘中异动 股价大涨5.13%报95.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2387453012","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387453012?lang=zh_cn&edition=full","pubTime":"2023-11-30 00:57","pubTimestamp":1701277069,"startTime":"0","endTime":"0","summary":"北京时间2023年11月30日00时57分,Ascendis Pharma A/S股票出现波动,股价大幅上涨5.13%。截至发稿,该股报95.27美元/股,成交量11.1359万股,换手率0.20%,振幅4.35%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Altamira Therapeutics Ltd涨幅较大,Avenue Therapeutics Inc、Altamira Therapeutics Ltd、Tharimmune Inc较为活跃,换手率分别为228.22%、179.86%、176.92%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Altamira Therapeutics Ltd,振幅分别为343.60%、78.92%、74.35%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130005750806b05d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130005750806b05d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383259380","title":"Ascendis Pharma A/S盘中异动 股价大涨5.10%报93.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2383259380","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383259380?lang=zh_cn&edition=full","pubTime":"2023-11-14 23:41","pubTimestamp":1699976512,"startTime":"0","endTime":"0","summary":"北京时间2023年11月14日23时41分,Ascendis Pharma A/S股票出现异动,股价快速上涨5.10%。截至发稿,该股报93.99美元/股,成交量12.4639万股,换手率0.22%,振幅2.72%。Ascendis Pharma A/S股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Biocardia Inc、Paxmedica Inc、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Biocardia Inc、Paxmedica Inc、Tenax Therapeutics Inc较为活跃,换手率分别为436.27%、256.91%、93.73%,振幅较大的相关个股有Paxmedica Inc、Biocardia Inc、Geovax Labs Inc C/Wts 29/09/2025,振幅分别为124.56%、105.26%、65.20%。Ascendis Pharma A/S公司简介:Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111423415284761d48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111423415284761d48&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383725824","title":"Ascendis Pharma A/S2023财年第三财季实现净利润-1.76亿美元,同比减少3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2383725824","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383725824?lang=zh_cn&edition=full","pubTime":"2023-11-13 00:28","pubTimestamp":1699806482,"startTime":"0","endTime":"0","summary":"9月30日,Ascendis Pharma A/S公布财报,公告显示公司2023财年第三财季净利润为-1.76亿美元,同比减少3.53%;其中营业收入为52.25百万美元,同比增加239.51%,每股基本收益为-3.14美元。机构评级:截至2023年9月30日,当前有13家机构对Ascendis Pharma A/S目标价做出预测,其中目标均价为141.05美元,其中最低目标价为109.76美元,最高目标价为191.58美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113002812840befa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113002812840befa4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":0.0305},{"period":"1month","weight":-0.0355},{"period":"3month","weight":0.0095},{"period":"6month","weight":0.4908},{"period":"1year","weight":0.5411},{"period":"ytd","weight":0.1203}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司,该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品,TransCon人生长激素或生长激素TransCon,每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037189},{"month":2,"riseRate":0.5,"avgChangeRate":0.037735},{"month":3,"riseRate":0.5,"avgChangeRate":0.039038},{"month":4,"riseRate":0.3,"avgChangeRate":-0.046884},{"month":5,"riseRate":0.5,"avgChangeRate":0.004945},{"month":6,"riseRate":0.555556,"avgChangeRate":0.01785},{"month":7,"riseRate":0.666667,"avgChangeRate":0.002177},{"month":8,"riseRate":0.666667,"avgChangeRate":0.086396},{"month":9,"riseRate":0.555556,"avgChangeRate":0.037325},{"month":10,"riseRate":0.444444,"avgChangeRate":0.006164},{"month":11,"riseRate":0.777778,"avgChangeRate":0.039978},{"month":12,"riseRate":0.444444,"avgChangeRate":0.049536}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}